BRCA1 and ovarian cancer: In this paper, we conducted a large genome-wide CNV analysis of 2500 BRCA1 pathogenic variant carriers, with or without breast and/or ovarian cancer, using a previously published SNP-based genome-wide association study.14 To maximize the sensitivity for CNV discovery, multiple CNV calling algorithms were applied to the data set.